ahlam1399
09-25-2015, 01:03 AM
Top U.S. doctors say pricey cholesterol ***** best for limited group
BOSTON, Sept 24 (Reuters) - Top U.S. heart doctors said on Thursday that newly developed cholesterol treatments that cost more than $14,000 per year are best used for the small group of patients for which they have been approved, at least for **w.
http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/a2.img (http://da.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/ach.img (http://adchoice.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/ach.htm)http://pi.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/a2t.imghttp://pi2.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a246078/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=XWG0eW4Ryxc:r22rc-J1D8o:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=XWG0eW4Ryxc:r22rc-J1D8o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=XWG0eW4Ryxc:r22rc-J1D8o:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=XWG0eW4Ryxc:r22rc-J1D8o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=XWG0eW4Ryxc:r22rc-J1D8o:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/XWG0eW4Ryxc
BOSTON, Sept 24 (Reuters) - Top U.S. heart doctors said on Thursday that newly developed cholesterol treatments that cost more than $14,000 per year are best used for the small group of patients for which they have been approved, at least for **w.
http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/a2.img (http://da.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/ach.img (http://adchoice.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/ach.htm)http://pi.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/a2t.imghttp://pi2.feedsportal.com/r/238386304588/u/49/f/654213/c/35217/s/4a246078/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a246078/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=XWG0eW4Ryxc:r22rc-J1D8o:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=XWG0eW4Ryxc:r22rc-J1D8o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=XWG0eW4Ryxc:r22rc-J1D8o:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=XWG0eW4Ryxc:r22rc-J1D8o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=XWG0eW4Ryxc:r22rc-J1D8o:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/XWG0eW4Ryxc